1. Homepage
  2. Equities
  3. Netherlands
  4. Euronext Amsterdam
  5. Royal DSM N.V.
  6. News
  7. Summary
    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
Real-time Euronext Amsterdam  -  05/23 11:35:37 am EDT
139.30 EUR   +2.39%
05/12ROYAL DSM N.V. : Ex-dividend day for final dividend (optional)
FA
05/10Koninklijke DSM N.V. Declares Dividend for the Financial Year 2021, Payable as from 3 June 2022
CI
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Royal DSM : DSM announces agreement to increase its shareholding in Andre Pectin from 29% to 75%

02/04/2019 | 01:29pm EDT

DSM acquired a 29% stake in Andre Pectin in 2013. After settling a shareholders dispute, DSM has now agreed with the other shareholders to purchase an additional 46% stake in Andre Pectin for a consideration of about €150 million. This will increase DSM's total shareholding in the company to 75%. The total purchase price for this 75% holding represents an EV/EBITDA multiple of about 13x based on the 2019 expected EBITDA of the company, excluding synergies. The company sales are about €65m with an EBITDA margin above 25%.

The remaining 25% of shares in Andre Pectin continues to be held by the Shandong Andre Group Co., Ltd, that supplies raw materials and utilities. DSM will closely work with the Andre Group to continuously improve the operational performance of the company, ensuring reliable supply through its global sales network of high-quality (natural) pectin, while ensuring compliance with DSM's safety, health and sustainability standards in the company's operations.

In view of the transaction, DSM will consolidate the activities of Andre Pectin in its group results. The transaction is expected to close in Q1/Q2 2019.

Andre Pectin is located in Yantai, Shandong Province in China. The company is Asia's largest producer of apple and citrus pectin, hydrocolloids providing texture solutions for food, beverages and personal care, with premier access to the world's fastest growing specialty food ingredients market. Andre Pectin employs about 410 employees. The company has a strong organic sales and profit growth track record and generates attractive margins. It is a highly innovative company with a strong sustainability profile.

Together with DSM's majority stakes in DSM Zhongken Biotechnology Co., Ltd. and DSM Rainbow (Inner Mongolia) Biotechnology Co. Ltd., DSM has a strong hydrocolloid product portfolio with gellum gum, xanthan gum, wellan gum and pectin-based solutions, which DSM offers to the food, beverage and personal care markets.

Hydrocolloids are thickeners and stabilizers that dissolve, disperse or swell in water to provide a broad range of important functionalities and physical attributes including gelling, texture, mouthfeel, viscosity and suspension. Demand for hydrocolloids is driven by three underlying consumer trends: the quest for convenient foods and beverages, consumers' increasing demand for dairy and plant-based protein drinks and the trend towards clean labeling.

Disclaimer

Koninklijke DSM NV published this content on 04 February 2019 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 04 February 2019 18:28:02 UTC


© Publicnow 2019
All news about ROYAL DSM N.V.
05/12ROYAL DSM N.V. : Ex-dividend day for final dividend (optional)
FA
05/10Koninklijke DSM N.V. Declares Dividend for the Financial Year 2021, Payable as from 3 J..
CI
05/10Shareholders Vote Down Philips' Executive Compensation Plan
MT
05/10ROYAL DSM N.V. : Dividends
CO
05/08ROYAL DSM N.V. : Proxy Statments
CO
05/06ROYAL DSM N.V. : Share buyback
CO
05/06Public Joint Stock Company KuibyshevAzot acquired Volgaplast Compounding Ltd from Konin..
CI
05/06Public Joint Stock Company KuibyshevAzot acquired remaining 51% stake in Volgalon Ltd O..
CI
05/03GLOBAL MARKETS LIVE : BP, Pfizer, Expedia, Citigroup, Amazon...
05/03DSM earnings beat expectations as strong demand offsets inflation
RE
More news
Analyst Recommendations on ROYAL DSM N.V.
More recommendations
Financials
Sales 2022 10 077 M 10 769 M 10 769 M
Net income 2022 909 M 971 M 971 M
Net Debt 2022 897 M 958 M 958 M
P/E ratio 2022 26,7x
Yield 2022 1,88%
Capitalization 23 971 M 25 615 M 25 615 M
EV / Sales 2022 2,47x
EV / Sales 2023 2,34x
Nbr of Employees 21 358
Free-Float 94,5%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 139,30 €
Average target price 183,76 €
Spread / Average Target 31,9%
EPS Revisions
Managers and Directors
Dimitri de Vreeze Member-Management Board
Géraldine Matchett Member-Management Board
Thomas Leysen Chairman-Supervisory Board
Eileen A. Kennedy Member-Supervisory Board
Pradeep Pant Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
ROYAL DSM N.V.-31.29%24 698
NESTLÉ S.A.-11.17%320 212
MONDELEZ INTERNATIONAL, INC.-7.72%84 682
ARCHER-DANIELS-MIDLAND COMPANY24.28%47 267
THE KRAFT HEINZ COMPANY6.88%46 963
THE HERSHEY COMPANY6.98%42 556